|کد مقاله||کد نشریه||سال انتشار||مقاله انگلیسی||ترجمه فارسی||نسخه تمام متن|
|5666953||1407839||2017||3 صفحه PDF||ندارد||دانلود رایگان|
â¢Few data are available about the sensitivity of MRSA screening media for mecC-MRSA.â¢This study compared the ability of four commercial screening media to detect mecC-MRSA.â¢chromIDÂ® MRSA and BrillianceTM MRSA 2 showed high sensitivity for mecC-MRSA (â¥97.3%).â¢BBLTM CHROMagarÂ® MRSA II and MRSASelectTM did not detect 20.7% and 36.9% of mecC-MRSA.
In this study, the performances of four methicillin-resistant Staphylococcus aureus (MRSA) chromogenic screening media were compared for detecting mecC-positive MRSA. Using 111 clinical isolates representative of the various mecC-MRSA clones in Europe, chromIDÂ® MRSA (bioMÃ©rieux) and BrillianceTM MRSA 2 (Oxoid Ltd.) showed higher sensitivity (99.1% and 97.3%, respectively) than BBLTM CHROMagarÂ® MRSA II (BD Diagnostics) and MRSASelectTM (Bio-Rad) (79.3% and 63.1%, respectively) (Pâ<0.0001). These findings have important implications for effective public health diagnostics and epidemiological surveillance of MRSA.
Journal: International Journal of Antimicrobial Agents - Volume 50, Issue 2, August 2017, Pages 263-265